Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy
Nikolien S van De Ven(London School of Hygiene & Tropical Medicine), Andrew Hill(University of Liverpool), Christopher Redd(Université de Tours), Anna Garratt(Cardiff and Vale University Health Board), Polly Clayden, Jacob Levi(Royal Free London NHS Foundation Trust), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Anton Pozniak
Cited by 37
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697